Compare Honest Company Inc (HNST) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honest Company Inc vs Repligen Corporation Common Stock — how do they compare? Honest Company Inc trades at $5.01 (market cap $543.40M), while Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is far larger — about 20.8× Honest Company Inc's market cap, and Honest Company Inc is more actively traded (1,509,522 versus 1,216,919). Which is the better fit depends on your goals — on Pluang, investors hold Honest Company Inc for 39 Days and Repligen Corporation Common Stock for 0 Days on average.
| HNST | RGEN | |
|---|---|---|
Market Cap | $543.40M | $11.31B |
Volume | 1,509,522 | 1,216,919 |
Sector | Consumer Staples | Health |
52-Week High | $5.95 | $194.57 |
52-Week Low | $2.10 | $102.87 |
Typical Hold Time | 39 Days | 0 Days |
Enterprise Value | $447.00M | $11.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HNST trades at $5.19, up 0.58% today, with a neutral technical signal and mixed earnings performance. The company shows improving cash flow trends with $14.15M net cash flow in 2025, though revenue declined to $371.32M with a net loss of $15.69M. Recent Q2 2026 earnings beat expectations with $0.04 EPS, while strategic exits continue to reshape the business.
The stock presents a turnaround story with improving profitability metrics but faces execution risks amid revenue pressure. Analyst consensus is mixed with a $5.30 price target, representing modest upside potential. Key risks include sustained profitability challenges and competitive pressures in the personal care sector.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Honest Company Inc
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
